From chemotherapy towards targeted therapies in CLL
A short discussion of the unmet needs of CLL patients
Dr Moorman's highlights on mixed phenotype acute leukemia (MPAL) from ASH 2016
Myeloma 2016: Panel discussion on the status of genomics
Chng Wee Joo et al.
How can we monitor a patient’s quality of life?